Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114598514 | 11459851 | 4 | F | 20160623 | 20150904 | 20160701 | EXP | CA-TAKEDA-2015MPI004896 | TAKEDA | 53.00 | YR | M | Y | 100.30000 | KG | 20160701 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114598514 | 11459851 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | 21602 | INJECTION | |||||||||
| 114598514 | 11459851 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | 1.5 MG/M2, UNK | 21602 | 1.5 | MG/M**2 | INJECTION | |||||||
| 114598514 | 11459851 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 20 MG, 1/WEEK | N | 0 | 20 | MG | /wk | ||||||
| 114598514 | 11459851 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | N | 0 | |||||||||
| 114598514 | 11459851 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | N | 0 | |||||||||
| 114598514 | 11459851 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | N | 0 | |||||||||||
| 114598514 | 11459851 | 7 | SS | PAMIDRONATE | PAMIDRONATE DISODIUM | 1 | Intravenous (not otherwise specified) | 90 MG, MONTHLY | 0 | 90 | MG | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114598514 | 11459851 | 1 | Plasma cell myeloma |
| 114598514 | 11459851 | 2 | Amyloidosis |
| 114598514 | 11459851 | 3 | Plasma cell myeloma |
| 114598514 | 11459851 | 4 | Amyloidosis |
| 114598514 | 11459851 | 5 | Plasma cell myeloma |
| 114598514 | 11459851 | 6 | Amyloidosis |
| 114598514 | 11459851 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114598514 | 11459851 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114598514 | 11459851 | Apnoea | |
| 114598514 | 11459851 | Disease progression | |
| 114598514 | 11459851 | Fatigue | |
| 114598514 | 11459851 | Haemorrhoids | |
| 114598514 | 11459851 | Increased tendency to bruise | |
| 114598514 | 11459851 | Macroglossia | |
| 114598514 | 11459851 | Oedema | |
| 114598514 | 11459851 | Oedema peripheral | |
| 114598514 | 11459851 | Rash | |
| 114598514 | 11459851 | Skin atrophy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114598514 | 11459851 | 1 | 201311 | 0 | ||
| 114598514 | 11459851 | 2 | 201403 | 0 | ||
| 114598514 | 11459851 | 4 | 201311 | 0 | ||
| 114598514 | 11459851 | 5 | 201311 | 2016 | 0 |